期刊文献+
共找到72篇文章
< 1 2 4 >
每页显示 20 50 100
非洲输入性恶性疟91例临床分析 被引量:21
1
作者 王忠磊 王玉茹 +1 位作者 付婷霞 毛德华 《中国血吸虫病防治杂志》 CAS CSCD 2013年第3期324-325,共2页
目的探索非洲输入性恶性疟的临床特征和早期诊断、治疗的方法。方法回顾性分析91例非洲输入性恶性疟的临床资料。结果91例输入性恶性疟疾患者均有蚊虫叮咬史。临床表现复杂多样,可出现发热、头痛、畏寒、腹泻、贫血、血小板减少、蛋白... 目的探索非洲输入性恶性疟的临床特征和早期诊断、治疗的方法。方法回顾性分析91例非洲输入性恶性疟的临床资料。结果91例输入性恶性疟疾患者均有蚊虫叮咬史。临床表现复杂多样,可出现发热、头痛、畏寒、腹泻、贫血、血小板减少、蛋白尿、肝功能损害、肝脾肿大等表现。应用蒿甲醚联合伯氨喹临床治愈率为100%。结论早期诊断,及时、合理的处理是治疗输入性恶性疟疾的关键。蒿甲醚联合伯氨喹对输入性恶性疟疾有显著的临床疗效,副作用少,作用迅速,复燃率低。 展开更多
关键词 恶性疟 输入性疟疾 临床特点 蒿甲醚 伯氨喹
原文传递
改进荧光光谱法研究药物与血清白蛋白的相互作用 被引量:15
2
作者 谭韬 黄锐 夏之宁 《分析化学》 SCIE EI CAS CSCD 北大核心 2007年第10期1415-1420,共6页
为了解决蛋白与药物分子的荧光光谱相互作用分析存在的缺点,采用小分子为荧光检测对象,以血清白蛋白(SA)为猝灭剂,研究了模拟生理条件(pH=7.4)下伯氨喹、十二烷基苯磺酸钠和西酞普兰与SA的相互作用。测得伯氨喹、十二烷基苯磺酸钠和西... 为了解决蛋白与药物分子的荧光光谱相互作用分析存在的缺点,采用小分子为荧光检测对象,以血清白蛋白(SA)为猝灭剂,研究了模拟生理条件(pH=7.4)下伯氨喹、十二烷基苯磺酸钠和西酞普兰与SA的相互作用。测得伯氨喹、十二烷基苯磺酸钠和西酞普兰与SA的结合常数Kb分别为8.16×104L/mol、4.14×106L/mol和6.08×107L/mol。这种改进荧光光谱法能更准确和全面地表达出SA与药物的相互作用信息。通过紫外吸收光谱相互作用分析法对改进方法进行了验证。并推测出药物与蛋白之间存在一种"点对面"的作用方式。 展开更多
关键词 荧光光谱法 牛血清白蛋白 相互作用 伯氨喹 西酞普兰 十二烷基苯磺酸钠
下载PDF
克林霉素联合伯氨喹补救治疗非HIV感染的肺孢子菌肺炎患者的效果 被引量:16
3
作者 王玺 王广发 +3 位作者 金哲 黄珺君 牟向东 章巍 《中华医学杂志》 CAS CSCD 北大核心 2017年第22期1734-1736,共3页
目的观察克林霉素联合伯氨喹(C-P方案)补救治疗非人类免疫缺陷病毒(HIV)感染的肺孢子菌肺炎(PCP)患者的效果。 方法回顾性分析2010年1月至2016年5月北京大学第一医院使用C-P方案补救治疗的非HIV感染的PCP患者病例资料,评价其... 目的观察克林霉素联合伯氨喹(C-P方案)补救治疗非人类免疫缺陷病毒(HIV)感染的肺孢子菌肺炎(PCP)患者的效果。 方法回顾性分析2010年1月至2016年5月北京大学第一医院使用C-P方案补救治疗的非HIV感染的PCP患者病例资料,评价其临床疗效。 结果共纳入19例非HIV感染的PCP患者,平均年龄(44.4±16.1)岁。患者均有糖皮质激素用药史,临床症状表现为发热、干咳和进行性加重的呼吸困难。该组患者均通过诱导痰或支气管肺泡灌洗液六胺银染色镜检确诊。其中,13例患者因一线治疗失败、6例患者因不能耐受甲氧苄啶/磺胺甲唑(TMP-SMX)而换用C-P方案补救治疗。19例患者中10例治愈,9例死亡。一线治疗失败的13例患者中4例治愈,而不能耐受TMP-SMX的6例患者均治愈(P=0.011)。发生不良反应3例,均为高铁血红蛋白血症。 结论非HIV感染的PCP患者一线治疗失败或不耐受时采用C-P方案补救治疗仍有可能收效。 展开更多
关键词 肺炎 肺囊虫性 HIV 克林霉素 伯氨喹 治疗结果
原文传递
The Technology for Preparation of Generic (Monoenantiomeric) Antimalarial Drug Primaquine by Using Supercritical Fluid Chromatography. Separation of Primaquine from Quinocide: Simultaneous Resolution of the Enantiomers of Primaquine and Their Separation from Quinocide in One Run 被引量:6
4
作者 Ilia Brondz Anton Brondz 《American Journal of Analytical Chemistry》 2012年第12期884-890,共7页
Malaria is one of the most harmful diseases on the globe. According to the World Health Organization (WHO), several million people die every year from malaria, and most of them are children. Hundreds of millions of fr... Malaria is one of the most harmful diseases on the globe. According to the World Health Organization (WHO), several million people die every year from malaria, and most of them are children. Hundreds of millions of fresh cases of ma- laria are registered by the WHO every year, and more than one-third of the earth’s population lives in malaria-endemic areas. Primaquine is an important antimalarial drug because it has gametocytocidal properties and prevents relapse in most cases. However, primaquine is a highly toxic substance, especially to the Negroid race (in Africa, Australia and North, Latin and South America) and some others. Negroid male children are most vulnerable to the toxic effects of primaquine. The toxicity of primaquine can be enhanced in mixtures with other antimalarial drugs. In the present study, unprocessed primaquine and primaquine tablets highly contaminated with quinocide (I. Brondz, Historical Overview of Chromatography and Related Techniques in Analysis of Antimalarial Drug Primaquine (Editor I. Brondz), Nova Sci- ence Publishers, Inc. (2011) ISSN 978-1-61761-944-1) are discussed versus monoenantiomeric primaquine as a drug. The contamination of primaquine with quinocide enhances the toxicity of primaquine by additive or synergistic action. The use of contaminated primaquine can be harmful. Development of a useful antimalarial vaccine can take a decade or longer. This paper describes the possibility of preparing antimalarial generic monoenantiomeric primaquine, free of both quinocide contamination and the ineffective enantiomer of primaquine, using fractionation by supercritical fluid chromatography equipped with a new experimental High Resolution Isomer Column (HRIC). By this approach, it is pos- sible to produce a significant amount of pharmacologically active enantiomer of primaquine at relatively low cost for a broad range of patients sensitive to contaminated primaquine. Leading pharmacopoeias should no longer deny the pre- sence of the toxic contaminant quinocide in relatively high c 展开更多
关键词 primaquine Quinocide High RESOLUTION Isomer COLUMN Monoenantiomeric primaquine Malaria SFC New TECHNOLOGY COLUMN HRIC
下载PDF
蒿甲醚伍用伯氨喹治疗恶性疟的研究 被引量:9
5
作者 黄建荣 高英起 Nganawei Elie 《中国寄生虫学与寄生虫病杂志》 CAS CSCD 北大核心 2001年第5期308-309,共2页
目的 观察蒿甲醚伍用伯氨喹治疗恶性疟的疗效和副作用。 方法 在中非共和国选择恶性疟12 1例 ,随机分为两组。伍用组 :口服蒿甲醚 80mg ,qd× 5d ,首日蒿甲醚 16 0mg加服伯氨喹 3片 (含基质 7 5mg ,qd× 3~ 4d)治疗 32例 ;... 目的 观察蒿甲醚伍用伯氨喹治疗恶性疟的疗效和副作用。 方法 在中非共和国选择恶性疟12 1例 ,随机分为两组。伍用组 :口服蒿甲醚 80mg ,qd× 5d ,首日蒿甲醚 16 0mg加服伯氨喹 3片 (含基质 7 5mg ,qd× 3~ 4d)治疗 32例 ;肌注蒿甲醚加服伯氨喹 ,治疗 2 9例 ;对照组 :单用口服蒿甲醚治疗 33例和肌注蒿甲醚治疗 2 7例 ,B组、C组和D组所用剂量与疗程均同A组。上述病例于用药前及后 6、 14、 2 1、及 2 8d各随访1次 ,密切观察病例的临床症状与体征变化。 结果 A组、B组、C组和D组病例的平均退热时间分别为(47 6± 15 7)、 (36 9± 10 7)、 (48 5± 18 4 )和 (42 2± 9 5 )h。其临床治愈率依次为 84 4 %、 10 0 %、 90 1和96 3% ,其复燃率依次为 6 3%、 3 4 %、 2 1 2 %和 18 5 %。 4组药物副作用均轻。 结论 蒿甲醚伍用伯氨喹及单用蒿甲醚 (口服或肌注 )对恶性疟治疗作用均良好 。 展开更多
关键词 疟疾 恶性疟 抗疟药物 蒿甲醚 伯氨喹 临床疗效
下载PDF
青蒿琥酯与伯喹联用对间日疟的疗效 被引量:8
6
作者 李兴亮 李崇珍 +2 位作者 黄德顺 何伟 刀清勇 《中国寄生虫病防治杂志》 CSCD 1998年第4期277-278,共2页
在云南南部,用青蒿琥酯600mg、伯喹180mg和氯喹1500mg、伯喹180mg,均以8d分服,分别治疗33例和35例间日疟患者,平均退热时间各为(18.7±3.9)h和(25.4±12.0)h,平均原虫转... 在云南南部,用青蒿琥酯600mg、伯喹180mg和氯喹1500mg、伯喹180mg,均以8d分服,分别治疗33例和35例间日疟患者,平均退热时间各为(18.7±3.9)h和(25.4±12.0)h,平均原虫转阴时间各为(28.7±6.1)h和(42.9±6.2)h。观察9个月内的复发率分别为33.3%和22.9%。结果表明,青蒿琥酯与伯喹联用治疗间日疟,其退热时间和原虫转阴时间均显著快于氯喹与伯喹联用组(P均<0.01),而复发率则无明显差别(P>0.05),且副反应更轻,患者易于接受。因此,是治疗间日疟的安全有效方案。 展开更多
关键词 青蒿琥酯 伯喹 间日疟 疟疾 治疗
下载PDF
伯氨喹与蒿甲醚联合治疗恶性疟疾的疗效评价 被引量:5
7
作者 司慧远 李晓娟 +2 位作者 姚宁 周平 孙莹 《空军医学杂志》 2015年第1期37-39,共3页
目的评价伯氨喹与蒿甲醚联合治疗恶性疟疾的疗效。方法选择2013年5月—2014年3月坦桑尼亚中坦友谊医院住院的恶性疟疾100例,按设定的治疗策略随机分为治疗组和对照组各50例。对照组:肌内注射80 mg蒿甲醚,1 d-1,连续治疗7 d,首次剂量160 ... 目的评价伯氨喹与蒿甲醚联合治疗恶性疟疾的疗效。方法选择2013年5月—2014年3月坦桑尼亚中坦友谊医院住院的恶性疟疾100例,按设定的治疗策略随机分为治疗组和对照组各50例。对照组:肌内注射80 mg蒿甲醚,1 d-1,连续治疗7 d,首次剂量160 mg;治疗组:在对照组的基础上,加服22.5 mg伯氨喹,1 d-1,连续服用8 d。依据恶性疟疾临床治愈标准,评价2组患者出院时疗效(痊愈、无效)并观察治疗期间的不良反应和治愈患者出院后28 d内的复发情况。结果治疗组和对照组痊愈、无效、复发率分别为98%、0、2%和82%、4%、14%,差异有统计学意义(P<0.05);总不良反应发生率分别为8%、16%,2组间差异有统计学意义(P<0.05)。结论伯氨喹与蒿甲醚联合治疗可以提高恶性疟疾疗效,降低复发率,不良反应更少。 展开更多
关键词 伯氨喹 蒿甲醚 恶性疟疾 疗效
下载PDF
云南省1例伯氨喹诱发溶血患者的G6PD基因编码区突变分析及酶蛋白空间结构预测 被引量:5
8
作者 董莹 刘淑萍 +3 位作者 徐艳春 刘言 邓艳 陈梦妮 《中国寄生虫学与寄生虫病杂志》 CAS CSCD 北大核心 2019年第4期399-405,共7页
目的分析伯氨喹诱发溶血患者的葡萄糖-6-磷酸脱氢酶(G6PD)基因突变对空间结构形成的影响。方法于2018年5月18日采集1例因服用伯氨喹出现溶血反应、G6PD酶活性下降75%的间日疟病例血样。提取血样的人基因组DNA,通过PCR分别扩增含G6PD基因... 目的分析伯氨喹诱发溶血患者的葡萄糖-6-磷酸脱氢酶(G6PD)基因突变对空间结构形成的影响。方法于2018年5月18日采集1例因服用伯氨喹出现溶血反应、G6PD酶活性下降75%的间日疟病例血样。提取血样的人基因组DNA,通过PCR分别扩增含G6PD基因exon2、exon3-7、exon8-9和exon10-13等12个外显子的片段并测序。整理获得的DNA序列与G6PD基因野生型、突变型序列比对,以确认12个外显子分别的起止点并拼接成exon2-13外显子的cDNA序列。用MEGA5.04软件分析cDNA序列的错义突变、同义突变和进行氨基酸链转换。采用SWISS-MODEL预测氨基酸链空间结构(www.swissmodel.expasy.org/interactive),PyMOL2.2.0软件修饰空间结构预测图。结果间日疟患者血样基因组经4个PCR反应体系扩增,分别获得含G6PD基因exon2、exon3-7、exon8-9、exon10-13外显子的336、2277、976和1421bp等4种目标产物。由测序结果整理获得12个外显子的cDNA链为1545bp,与野生型序列比对的同义突变、错义突变位点分别为c.1311T>C和c.1376G>T,导致437、459氨基酸呈Y/Y不变和R/L变异,空间位置均未在G6PD与NADP^+、乙醇酸配体的结合区。515aa氨基酸链的二聚体空间结构模型GMQE、QMEAN分别为0.97和0.66,建模质量高,与野生型模型(6eO7.1.A)比对,459氨基酸均处于模型表面,与NADP^+配体的结合区均包括238、357等16个残基;四聚体的建模质量略差,乙醇酸的配体结合区仅为47等6个残基,少于野生型的11个。结论G6PD基因编码区C.1311T>C同义突变与C.1376G>T错义突变同时存在,可能不影响该患者G6PD二个亚基的聚合及其与NADP+配体的结合,但四聚体的形成受到干扰。 展开更多
关键词 云南省 伯氨喹 溶血 葡萄糖-6-磷酸脱氢酶 突变 空间结构
原文传递
35例输入性疟疾流行病学及临床特征分析 被引量:4
9
作者 朱其荣 梅小平 《川北医学院学报》 CAS 2015年第1期77-80,共4页
目的:分析南充地区输入性疟疾的流行病学及临床特征,为提高早期诊断和改善预后提供理论依据。方法:对我院2010年1月至2013年8月收治的35例输入性疟疾患者的流行病学、临床表现、实验室检查、临床转归进行回顾性分析。结果:输入性疟疾患... 目的:分析南充地区输入性疟疾的流行病学及临床特征,为提高早期诊断和改善预后提供理论依据。方法:对我院2010年1月至2013年8月收治的35例输入性疟疾患者的流行病学、临床表现、实验室检查、临床转归进行回顾性分析。结果:输入性疟疾患者主要为外出务工男性,临床表现各异,大多患者除畏寒、发热、热退后出汗外,伴随有乏力、纳差、寒战、头痛、肌肉酸痛,部分患者伴随咳嗽、咳痰、腹痛、腹泻、身黄、尿黄。实验室检测主要为白细胞、中性粒细胞百分比升高、血红蛋白、血小板下降,肝肾功、电解质异常。蒿甲醚治疗效果佳,蒿甲醚联合伯氨喹治疗复发病例有效。脑型疟疾预后差。结论:输入性疟疾临床表现复杂多样,详细询问流行病学史能提高早期诊断率,及时抗疟原虫治疗、有效的综合治疗能有效提高治愈率,改善预后。 展开更多
关键词 输入性疟疾 流行病学 临床特征 蒿甲醚 伯氨喹
下载PDF
Effect of Primaquine on Gametocyte Carriage in the Case-Management of Uncomplicated Falciparum Malaria with Acts: Nigerian Perspective
10
作者 A. B. Tsuung S. L. Pitmang F. L. Dassak 《Advances in Infectious Diseases》 2018年第2期39-53,共15页
Background: Drugs that kill or inhibit sexual stages of Plasmodium such as Primaqiune (PQ) could potentially amplify or synergize the impact of first line antimalarials by blocking transmission to mosquitoes. This stu... Background: Drugs that kill or inhibit sexual stages of Plasmodium such as Primaqiune (PQ) could potentially amplify or synergize the impact of first line antimalarials by blocking transmission to mosquitoes. This study examined the effect of Primaquine on gametocyte carriage in the case management of uncomplicated falciparum malaria with artemisinin-based combination therapy (ACT) with the overall purpose of possibly recommending it as an adjunct drug for malaria control. Methods: A total of 181 patients with uncomplicated falciparum malaria, normal glucose-6-phosphate dehydrogenase (G6PD) enzyme levels, and haemoglobin levels ≥ 8 g/dL completed this two-arm randomized blinded clinical trial to test the efficacy of a single dose PQ (0.75 mg/kg) on falciparum gametocytaemia. 88 subjects were assigned to a standard 3-day course of Dihydroartemisinin-Piperaquine (DHP) alone (n = 88) while 93 others had DHP combined with a single dose of PQ on day 3 (n = 93). A 28-day follow-up schedule carried out in the outpatient clinic of a Primary health facility in Vom, Plateau State Nigeria where study participants were seen on days 1, 3, 7 and then weekly to assess the presence of asexual parasites and gametocytes by microscopy. A Kaplan-Meier analysis was employed to determine the survival function of gametocytes on day 3. The data was analyzed using Epi info version 7.1.5. Results: With a gametocyte prevalence of 27.1%, gametocyte carriage rate was lower in the PQ group due to higher probability of clearing gametocytes (Breslow test χ2 = 8.306, df = 1, p = 0.004) and significantly less likely to harbor gametocytes by day 7 when compared to the DHP-alone group (χ2 = 6.218, df = 1, p = 0.013). Conclusion: Addition of single-dose 0.75 mg/kg PQ was associated with reduced gametocyte carriage as a result of faster gametocyte clearance and lower incidence of gametocyte development in DHP-treated patients. PQ as gametocytocidal drug may be useful in combination with artemisinin-based combination therapy (ACT) regimen to clear 展开更多
关键词 Malaria Artemisinin-Based Combination Therapy Plasmodium falciparum primaquine GAMETOCYTES Dihydroartemisinin-Piperaquine
下载PDF
咯萘啶与磺胺多辛-乙胺嘧啶单剂及两天疗法加伯氨喹治疗恶性疟的效果 被引量:2
11
作者 黄在松 蒙锋 符式刚 《中国寄生虫学与寄生虫病杂志》 CSCD 北大核心 1996年第4期314-317,共4页
目的:在海南省多重抗性恶性疟流行区,观察咯萘啶加伯氨喹与磺胺多辛-乙胺嘧啶加伯氨喹两种方案治疗恶性疟的效果。方法:采用咯萘啶与磺胺多辛-乙胺嘧啶各500mg、1000mg、50mg单剂口服以及3药各800mg、100... 目的:在海南省多重抗性恶性疟流行区,观察咯萘啶加伯氨喹与磺胺多辛-乙胺嘧啶加伯氨喹两种方案治疗恶性疟的效果。方法:采用咯萘啶与磺胺多辛-乙胺嘧啶各500mg、1000mg、50mg单剂口服以及3药各800mg、1000mg、50mg2d分服,同时各加伯氨喹45mg2d分服,治疗恶性疟各50例。结果:平均退热时间分别为39.8±27.2h和42.1±20.5h,原虫无性体转阴时间分别为46.9±13.3h和51.0±14.2h,24h减虫率分别为80%和78%。28d治愈率皆为100%。药物副反应较轻,一般不需特殊处理,但两组各有3例发生溶血反应,心电图有窦性心动过缓或伴窦性心律不齐。结论:表明两种方案均可治愈抗性恶性疟。 展开更多
关键词 多重抗性 恶性 疟疾 咯萘啶 磺胺多辛 乙胺嘧啶
下载PDF
细胞色素P4502D6遗传多态性与抗疟药研究进展 被引量:3
12
作者 邹春燕 何曦 +3 位作者 覃宇城 赵霞 杨照青 黄亚铭 《中国热带医学》 CAS 2021年第4期380-384,共5页
人类不同种族之间P450基因多态性存在明显的差异,并直接影响约90%临床常用药物在机体内的代谢和转化。英国牛津大学大数据研究所分析提示,目前广泛用于根治间日疟患者的伯氨喹啉药物已经不再适合临床用药,其理由是全球间日疟患者中有超... 人类不同种族之间P450基因多态性存在明显的差异,并直接影响约90%临床常用药物在机体内的代谢和转化。英国牛津大学大数据研究所分析提示,目前广泛用于根治间日疟患者的伯氨喹啉药物已经不再适合临床用药,其理由是全球间日疟患者中有超过20%存在CYP2D6基因代谢受损,导致对患者肝脏内潜伏期的休眠子根治无效,同时还有14%的间日疟患者存在葡萄糖6-磷酸脱氢酶(G6PD)缺乏导致溶血,两类患者合计超过间日疟患者总数的34%。由此,改变了过去认为氯喹合并伯氨喹啉根治间日疟患者效果不佳是由于产生抗药性的看法。广西上林县发现非洲输入性间日疟患者采用标准剂量氯喹合并伯氨喹啉多次根治后仍然出现反复发作现象,经检测发现是由于CYP2D6基因代谢受损导致。研究小组尝试采用青蒿素类药物与阿奇霉素配伍进行根治后,至今2年多未见再复发。因此,对间日疟患者经常规根治药物治疗效果不佳时应开展CYP2D6检测。同时研究开发新的间日疟根治药物是目前全球所面临的重大课题。 展开更多
关键词 间日疟 根治 伯氨喹啉 CYP2D6
原文传递
Analytical Methods in the Quality Control of Scientific Publications Part V: The Fraud of Pseudoscientists Based on False Measurements and Method Development
13
作者 Ilia Brondz 《International Journal of Analytical Mass Spectrometry and Chromatography》 2015年第2期25-31,共7页
Despite the obvious frauds published in [1] [2] and the involvement of Editors and Editors in Chief of the journals in the publication of these fraudulent papers, the Editors in Chief of publishers have not taken any ... Despite the obvious frauds published in [1] [2] and the involvement of Editors and Editors in Chief of the journals in the publication of these fraudulent papers, the Editors in Chief of publishers have not taken any action to retract the fraudulent papers or to dismiss the corrupt editors. By this passivity, these Editors in Chief are supporting plagiarism, dissemination of fraudulent data, lies and making published information unreliable. In the present paper, we evaluate examples of bold, fraudulent publications and give the names of some Editors directly participating in concealing fraudulent publications, together with the names of Editors in Chief who also concealed and covered the facts of fraud and were reluctant to remove the fraudulent papers from circulation or to remove cheaters from editorial positions. The truth is universal and international;in contrast, the lie is individual and partisan, social, political, confessional, cultural and dirty. Knowledge is a truth that is part of the Universe. Lies are a tool of manipulation and can exist only in distinct environments that produce and support them. In this paper, we will show how artificial prefabricated analytical procedures were used to disseminate false data with the aim of substituting the truth with fraud. 展开更多
关键词 PLAGIARISM DISSEMINATION of False Data False Method Development Corrupt EDITORS Artificial Analytical Procedures primaquine Quinocide ANTIMALARIAL Drugs
下载PDF
Review: Can Toxic Substances Initiate Psychotic Behavior? Part I. Antimalarial Drugs
14
作者 Ilia Brondz 《Open Journal of Preventive Medicine》 2014年第7期561-572,共12页
During and after every military conflict or war, there appears to be rapports about military crimes which were done by military and civil personal of conflicting sides. The basis of these offences is different;however... During and after every military conflict or war, there appears to be rapports about military crimes which were done by military and civil personal of conflicting sides. The basis of these offences is different;however the common to these is psychological and psychical background. The psychological background is an indoctrination of troopers that all what they are doing is right, well for country, nation or defends religion, or ideology. The life and property of enemy (opponent) are less worth than their oven. But most important in this indoctrination is the direct or indirect insurances about the absence of responsibility and promises about free for punishment for these actions. These aspects are well known and well-studied. The psychical background is less studied and more diverse;however in all cases the components of stress are present. The stress can be physical, psychical or toxic. The physical and psychical stress of engaged in military conflict personal is well studied, its action both during the war and as postwar syndrome have sufficient explanations. The action of intoxication especially by contaminants in medical forms, or toxins to induce the criminal behavior of military personal is nearly unstudied. The exceptions are alcohol, psychogenic substances as narcotics, LSD and special doping agents. This paper presented the evidences of additional toxic stress by contaminates in medical forms and intoxication by toxins of military personal engaged in different conflicts during last decades. The hypothesis about the influences of the additional toxic stress by medication with low quality pharmaceutical forms and some toxins on inducing the crimes generally and war crimes by military personal is launched in the paper. In this part the investigation will be concentrated on antimalarial drugs, especially on contaminated primaquine. Primaquine has a special position in preventing malaria infection in areas of conflict on the territories of endemic malaria. The possibility of induction of psychotic cases which 展开更多
关键词 Contaminated MEDICAL FORMS primaquine TOXIC Contaminants MALARIA TOXIC Stress Induced by Contaminated MEDICAL FORMS
下载PDF
Analytical Methods in the Quality Control of Scientific Publications Part II: The Authors’, Reviewers’, Editors’ Responsibility, and the Publishers’ Authority
15
作者 Ilia Brondz 《International Journal of Analytical Mass Spectrometry and Chromatography》 2013年第2期81-89,共9页
Publication of scientific documents as research reports and original papers has an important place in displaying the authors’ knowledge, integrity, responsibility, and honesty. The same is true for the reviewers and ... Publication of scientific documents as research reports and original papers has an important place in displaying the authors’ knowledge, integrity, responsibility, and honesty. The same is true for the reviewers and editors. The authority of a publisher strongly depends on the qualifications of the experts who review the manuscripts, and the recommendations they provide to the authors and editors. The honesty of the authors, reviewers, and editors is of the utmost importance. The author of the paper titled “Analytical Methods in Quality Control of Scientific Publications”, which was published in theAmerican Journal of Analytical Chemistry, 2012, 3, 443-447 (DOI: 10.4236/ajac.2012.36058) had criticized the paper published by Dongreet al., “Application of GC-EI-MS for the Identification and Investigation of Positional Isomer in Primaquine, an Antimalarial Drug, ”Journal of Pharmaceutical and Biomedical Analysis, 2005, 39, 111-116 (DOI: 10.1016/j.jpba.2005.03.019), for presenting falsifications in this publication. Neither the reviewer northe Edi-tor-in-Chief Bezhan Chankvetadze of the Journal of Pharmaceutical and Biomedical Analysishas reacted to accusations of falsification. If a reviewer and editor are poorly qualified, unprincipled, or even corrupt, as was suggested by Bob Grant inThe Scientistmagazine (http://www.the-scientist.com/display/55679/#ixzz0mmsPoMIS), it is not good enough to consider simply that the publisher / journal has a high ranking and is indexed in PubMed or the Institute for Scientific Information (ISI). In this editorial, we report a profound misunderstanding oralack of knowledge by the authors Shixue G., Zhuoyu L., and Wei W., in their paper published in ZhongguoYaoye China Pharmaceuticals, Vol. 14, No. 4, 2005, pp. 36-37 and a similar lack of professionalism by reviewers and editors. The influence and the role of internationally used pharmacopeias, such as The British Pharmacopoeia, European Pharmacopoeia, The United States Pharmacopeial Convention, and United States Pharmacopei 展开更多
关键词 primaquine ISOMERS ENANTIOMERS TLC SPURIOUS PUBLICATIONS Pharmacopeias
下载PDF
Analytical Methods in Quality Control of Scientific Publications Part IV: Fraud Ordered by the Pharmaceutical Industry
16
作者 Ilia Brondz 《International Journal of Analytical Mass Spectrometry and Chromatography》 2014年第4期103-112,共10页
In a series of papers under the common title: “Analytical Methods in Quality Control of Scientific Publications,” cases of undisputable breaches of publication ethics and breaches of acceptable rules in the publicat... In a series of papers under the common title: “Analytical Methods in Quality Control of Scientific Publications,” cases of undisputable breaches of publication ethics and breaches of acceptable rules in the publication of scientific information have been presented. Clear cases of fraud, falsification by some authors, and unqualified review of papers by reviewers and editors were presented in: Analytical Methods in Quality Control of Scientific Publications, (2012) American Journal of Analytical Chemistry, Vol. 3, No. 6, pp. 443-447 DOI:10.4236/ajac.2012.36058. The place of authors, reviewers, editors, and publisher was discussed in: Editorial: Analytical Methods in Quality Control of Scientific Publications Part II: The Authors’, Reviewers’, Editors’ Responsibility, and the Publishers’ Authority, (2013) International Journal of Analytical Mass Spectrometry and Chromatography, Vol. 1, No. 2, pp. 81-89 http://dx.doi.org/10.4236/ijamsc.2013.12010, Analytical Methods in Quality Control of Scientific Publications Part III: Publishers’ Ethics and Editors’ Com- plicity, (2014) International Journal of Analytical Mass Spectrometry and Chromatography, Vol. 2, No. 3, pp. 77-102. DOI: 10.4236/ijamsc.2014.23008 and in the book Historical Overview of Chromatography and Related Techniques in Analysis of Antimalarial Drug Primaquine (Editor, Ilia Brondz) Nova Science Publishers, Inc., (2011) ISSN 978-1-61761-944-1. Here, the corrupting influence of the pharmaceutical industry as a customer and employer of pseudoresearchers and corrupt editors and even to corrupt journal publishers for publication of fraudulent information and pseudoscientific data will be discussed by identifying the authors of pseudoscientific publications, the editors who gave the green light for the fraudulent publication, and the pharmaceutical companies involved. Documentation will be given to support the accusations of fabricated fraudulent “scientific” data, and the publication of such data without sufficient revision and sufficient b 展开更多
关键词 Pharmaceutical Industry Corruptive Customer PREFABRICATED Fraudulent Scientific Data Pseudoscientific PUBLICATIONS Breaches of PUBLICATION ETHICS Pseudoscientists primaquine Quinocide
下载PDF
Analytical Methods in Quality Control of Scientific Publications
17
作者 Ilia Brondz 《American Journal of Analytical Chemistry》 2012年第6期443-447,共5页
Plagiarism, fake or even falsified presentation has become a major plague for scientific publications. This paper is a response to personal appeal by David JW Lane the Editor-in-Chief of Research and Reports in Biodiv... Plagiarism, fake or even falsified presentation has become a major plague for scientific publications. This paper is a response to personal appeal by David JW Lane the Editor-in-Chief of Research and Reports in Biodiversity Studies to support and promote the international author standards as developed by COPE for authors and editors-in-chief posted to me April 3rd 2012 (International standards for editors and authors http://www.dovepress.com/rrbscope.t9699812). As corresponding author for more than 100 scientific papers, dozens of scientific reviews, several chapters in scientific books, and author and editor of a book Historical Overview of Chromatography and Related Techniques in Analysis of Antimalarial Drug Primaquine, and as a reviewer of Journal of Chromatography, Journal of Chromatography A, Journal of Chromatography B: Biomedical Sciences and Applications, Lipids, Journal of General Microbiology, Journal of Clinical Microbiology, Journal of Microbiological Methods, Oral Microbiology and Immunology, Analytica Chimica Acta, Mycological Research and Journal of Pharmaceutical and Biomedical Analysis, and member of editorial board of Electronic Components and Systems, American Journal of Analytical Chemistry, ISRN Chromatography and Open Journal of Clinical Diagnostics I was adhered to a new ethical and moral standards in scientific publications. The presented paper is an example of use the analytical methods in visualizing of plagiarism and falsification in the published scientific literature. It is obvious that some of scientific publications need careful quality control. Some papers should have been rejected but were not. These papers clearly pollute the field of scientific information. It is not always easy to demonstrate inappropriate presentation even when many supporting facts are available. The facts should be obvious;there should be no hesitation about the quality or value of a paper presented for consideration to be published. Plagiarism is most common and harmful phenomenon in scientific publication 展开更多
关键词 ANALYTICAL METHODS in QUALITY Control 13C NMR SPECTROSCOPY primaquine Quinocide
下载PDF
伯氨喹治疗葡萄糖-6-磷酸脱氢酶缺乏症疟疾患者溶血风险的荟萃分析 被引量:1
18
作者 彭书杰 伍国俊 赵会民 《中国感染与化疗杂志》 CAS CSCD 北大核心 2022年第5期556-562,共7页
目的评估不同剂量伯氨喹治疗葡萄糖-6-磷酸脱氢酶(G-6-PD)缺乏症疟疾患者溶血风险。方法计算机检索PubMed、Embase、Web of Science、Cochrane Library、the Cochrane Infectious Diseases Group(CIDG)、中国知网、万方以及维普等中英... 目的评估不同剂量伯氨喹治疗葡萄糖-6-磷酸脱氢酶(G-6-PD)缺乏症疟疾患者溶血风险。方法计算机检索PubMed、Embase、Web of Science、Cochrane Library、the Cochrane Infectious Diseases Group(CIDG)、中国知网、万方以及维普等中英文数据库,收集G-6-PD缺乏症单疗程或短期疗程使用伯氨喹的相关文献,检索时限为建库至2021年7月30日,采用RevMan 5.4软件进行统计学分析。结果共纳入7篇文献,其中290例G-6-PD缺乏症患者,1022例酶活性正常患者。分析结果显示:与安慰剂相比,不同剂量伯氨喹治疗疟疾患者G-6-PD缺乏症第7天,血红蛋白水平均有不同程度降低;但高剂量治疗组血红蛋白较基线下降百分比更大(P<0.05),中度及以上贫血风险显著增大(RR=4.50,95%CI:2.29~8.84,P<0.0001);中剂量治疗组血红蛋白较基线下降百分比略小于酶活性正常患者(MD=-4.99%,95%CI:-9.96%~-0.02%,P=0.05),但与安慰剂组相比,血红蛋白较基线下降百分比差异无统计学意义(MD=-1.52%,95%CI:-7.73%~4.69%,P=0.63);而低剂量治疗组血红蛋白较基线下降百分比、中度及以上贫血风险差异无统计学意义。结论高剂量伯氨喹治疗G-6-PD缺乏症疟疾患者诱发溶血风险高于中低剂量,尤其是低剂量更加安全。 展开更多
关键词 伯氨喹 葡萄糖-6-磷酸脱氢酶缺乏症 疟疾 溶血 荟萃分析
下载PDF
氯喹和伯氨喹治疗缅甸拉咱地区间日疟的效果评价 被引量:2
19
作者 梁桂亮 张再兴 +1 位作者 孙晓东 王剑 《中国病原生物学杂志》 CSCD 2010年第9期672-675,共4页
目的了解氯喹加伯氨喹治疗缅甸拉咱地区间日疟的效果。方法按随机数字表将入选的病人随机分成两组(A组和B组)。A组采用氯、伯氨喹8 d疗法治疗,即成人给予氯喹口服总剂量1 200 mg和伯氨喹口服总剂量180mg;B组采用氯、伯氨喹14 d疗法治... 目的了解氯喹加伯氨喹治疗缅甸拉咱地区间日疟的效果。方法按随机数字表将入选的病人随机分成两组(A组和B组)。A组采用氯、伯氨喹8 d疗法治疗,即成人给予氯喹口服总剂量1 200 mg和伯氨喹口服总剂量180mg;B组采用氯、伯氨喹14 d疗法治疗,即成人给予氯喹口服总剂量1 500 mg或25 mg(基质)/kg体重、伯氨喹口服总剂量210 mg[或0.25 mg(基质)/kg体重]。观察D0(服药后第1 d,之后类推)、D1、D2、D3、D7、D14、D21、D28,及2~6个月的临床疗效和复发情况。结果纳入的129例间日疟患者,111例完成D28随访观察。A、B两组原虫无性体平均转阴时间为(41.05±14.01)h和(35.93±12.62)h,差异有统计学意义(t=2.02,P〈0.05);两组平均退热时间为(26.29±10.72)h和(23.46±11.40)h,差异无统计学意义(t=1.454,P〉0.05)。A组与B组D1、D2、D3较D0无性体密度下降率分别为92.80%、99.90%、100.0%和94.18%、99.50%、100%。B组在D14随访复查1例原虫复现。A组随访复发率为3.51%(2/57),B组为90.26%(5/54),差异无统计学意义(χ2=0.607,P〉0.05)。结论氯喹加伯氨喹两种疗法对缅甸拉咱地区间日疟患者预防复发的效果相同;对该地区的现症间日疟患者采用上述两种疗法治疗效果良好。 展开更多
关键词 间日疟 氯喹 伯氨喹 复发 缅甸
原文传递
氯喹加伯氨喹八日疗法对间日疟患者治疗效果的评价研究 被引量:2
20
作者 梁桂亮 张再兴 +1 位作者 孙晓东 王剑 《国际医学寄生虫病杂志》 CAS 2010年第4期202-204,共3页
目的 了解我国氯喹加伯氨喹八日疗法对中缅边境地区间日疟患者的治疗效果.方法 便于追踪、满足纳入条件的单纯间日疟患者且同意参加本次研究者被纳入观察.成人给予氯喹口服总剂量1 200 mg(基质)/3 d,D0给予600 mg,D1、D2分别给予300 ... 目的 了解我国氯喹加伯氨喹八日疗法对中缅边境地区间日疟患者的治疗效果.方法 便于追踪、满足纳入条件的单纯间日疟患者且同意参加本次研究者被纳入观察.成人给予氯喹口服总剂量1 200 mg(基质)/3 d,D0给予600 mg,D1、D2分别给予300 mg;联合伯氨喹口服总剂量(基质)180 mg/8 d,D0-D7每次的口服剂量是22.5 mg;患者被纳入观察的第1天作为D0,且在D0、D1、D2、D3、D7、D14、D21和D28检查血涂片.结果 共67人纳入本次观察,其中57人完成D28随访观察.原虫无性体平均转阴时间为41.05±14.01 h、配子体平均转阴时间为20.25±12.86 h、原虫平均退热时间为26.29±10.72 h,至D28仍无原虫再现,57例患者临床及原虫治疗成功.结论 中缅边境地区的间日疟患者对我国的八日疗法敏感. 展开更多
关键词 氯喹 伯氨喹 间日疟原虫 八日疗法 中缅边境
原文传递
上一页 1 2 4 下一页 到第
使用帮助 返回顶部